Desk›Healthcare› Bharat Parenterals Ltd
Bharat Parenterals Ltd
BSE 541096 · NSE BPLPHARMA · ISIN INE365Y01019 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,538.65
+1.51%
BSE close, 28 August 2026
₹1,060.43 cr
0.7 cr shares · Micro cap
₹347.81 cr
as published
109.5× · 3.28×
EPS ₹14.05 · BV ₹469.10
234.02 / 16.02
₹ cr, as filed
24
6 selected · 25%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -3.5% |
|---|---|
| Against 52-week low | +74.8% |
| Day change | +1.51% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹14.05 |
|---|---|
| Price / earnings | 109.51× |
| Price / book | 3.28× |
| Book value — derived, price ÷ P/B | ₹469.10 |
| Return on equity | 2.99% |
| Operating margin | 14.20% |
| Net margin | 6.59% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 3.00%
- ROE as published
- 2.99%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 55.50 | 3.66 | 5.31 | 14.20% | 6.59% |
| Mar-26 · Q | 56.54 | 1.38 | 2.00 | 7.92% | 2.44% |
| FY25-26 | 234.02 | 16.02 | 23.24 | 14.38% | 6.85% |
Quarter on quarter
- Revenue, quarter on quarter
- -1.8%
- Net profit, quarter on quarter
- +165.2%
- Operating margin, quarter on quarter
- +628 bps
Disclosure profile 24 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Change in Directorate | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| Newspaper Publication | 7 |
| AGM / EGM | 2 |
| Board Meeting | 2 |
| General | 2 |
| Analyst / Investor Meet | 1 |
| Annual Report | 1 |
| Compliance Certificate | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 18 |
| Total | 24 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
24 filings · 6 selected · busiest 2026-08-05 and 2026-08-27
Filing rhythm · the twelve most recent
2026-08-272026-10-08
SelectedProcedural
Filings
24 in the window · 9 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
2 October 2026 ·
Newspaper Publication
Newspaper publication for the 1st EGM of FY 2026-27.
Company Update / Newspaper Publication View filing →
-
1 October 2026 ·
Intimation For Extra-Ordinary General Meeting Of The Company To Be Held On Friday, October 23, 2026.
Notice of Extra -Ordinary General Meeting of the Company to be held on Friday, October 23, 2026.
AGM/EGM / EGM View filing →
-
29 September 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting For The Board Approves The Preferential Issue.
Outcome of the board meeting for the board approves the Preferential Allotment
Board Meeting / Outcome of Board Meeting View filing →
-
24 September 2026 ·
Closure of Trading Window
Intimation for the closure of the trading Window in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Board Meeting Intimation for Fundraing Raising Through Preferential Issue.
Bharat Parenterals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/09/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Board Meeting / Board Meeting View filing →
-
14 September 2026 ·
Newspaper Publication
Public Notice for Newspaper advertisement dated September 12, 2026.
Company Update / Newspaper Publication View filing →
-
28 August 2026 ·
Newspaper Publication
Please find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19, 2026.
Company Update / Newspaper Publication View filing →
-
27 August 2026 ·
Intimation Under Regulation 36 Of The SEBI (LODR) Regulations, 2015.
Please find the enclosed copy of the letter dispatched by the company to the shareholders (whose email id not registered) for providing details to access the Annual Report for FY 2025-26.
Company Update / General View filing →
-
27 August 2026 ·
Intimation Of The Record Date For The Purpose Of The Dividend For FY 2025-26.
Intimation of Record Date for the purpose of Payment of Dividend for the FY 2025-26.
Corp. Action / Record Date View filing →
-
27 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for the Financial Year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
27 August 2026 ·
Notice Of 33Rd Annual General Meeting Of The Comapny Schedule On September 19, 2026.
Notice of 33rd Annual General Meeting of the Company.
AGM/EGM / AGM View filing →
-
24 August 2026 ·
Newspaper Publication
Intimation for publication of Pre-Newspaper Advertisement of the 33rd Annual General Meeting of the Company.
Company Update / Newspaper Publication View filing →
-
20 August 2026 ·
Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.
Intimation regarding permission to trade and Admission of Equity Shares to dealing on the National Stock Exchange of India Limited.
Company Update / General View filing →
-
14 August 2026 ·
Newspaper Publication
Please find the enclosed newspaper notice to the physical Shareholders informing them about the special window open for re-lodging the transfer deed.
Company Update / Newspaper Publication View filing →
-
11 August 2026 ·
Press Release / Media Release
Press release on Update on Expansion and Enhancement of the facility of Varenyam Biolifesciences Pvt Ltd, a Wholly Owned Subsidiary Company of Bharat Parenterals Limited
Company Update / Press Release / Media Release View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of an analyst and investor Meet under Regulation 30 of SEBI (LODR), Regulations, 2015.
Company Update / Analyst / Investor Meet View filing →
-
7 August 2026 ·
Newspaper Publication
Copy of newspaper advertisement for the Unaudited Financial Results for the Quarter ended on June 30, 2026.
Company Update / Newspaper Publication View filing →
-
5 August 2026 ·
Investor Presentation
Investor Presentation for the Quarter ended on June 30, 2026
Company Update / Investor Presentation View filing →
-
5 August 2026 ·
Change in Directorate
Re-appointment of Mr. Hemang Shah as Executive Director of the Company, Subject to approval of Shareholders in enuing AGM.
Company Update / Change in Directorate View filing →
-
5 August 2026 ·
Financial Results For The Quarter Ended On June 30, 2026
Unaudited Financial Results for the quarter ended on June 30, 2026.
Result / Financial Results View filing →
-
5 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting held on August 05, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
29 July 2026 ·
Newspaper Publication
Newspaper Advertisement under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulation, 2015.
Company Update / Newspaper Publication View filing →
-
28 July 2026 ·
Board Meeting Intimation for Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On June 30, 2026.
Bharat Parenterals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Unaudited Standalone and ....
Board Meeting / Board Meeting View filing →
RSS feed for Bharat Parenterals Ltd · the 50 most recent filings